Lymphoma Hub

What Lymphoma Hub does

Lymphoma Hub is an independent medical education platform operated by Scientific Education Support (SES), a UK-based medical education company headquartered in Thames Ditton. Founded in 2016, the platform delivers curated, web-based educational content on lymphoma and chronic lymphocytic leukemia (CLL) to hemato-oncology physicians globally, covering disease subtypes, therapeutics, clinical trials, expert opinions, drug updates, and live coverage of major hematology congresses including EHA, ICML, and ASH. Its core product is My Lymphoma Hub, a personalization layer that lets registered healthcare professionals bookmark content, receive alerts based on areas of interest, and view content recommendations; the broader site uses third-party Google Translate for multilingual accessibility and is hosted on a Next.js-based web platform.

Content is developed independently by SES in collaboration with an international expert steering committee of key opinion leaders from the US, Europe, Australia, and Japan. Editorial control is contractually separated from funders, with twelve disclosed pharmaceutical and biotech sponsors (AbbVie, BeOne Medicines, Caribou Biosciences, Miltenyi Biomedicine, Nurix Therapeutics, Roche, Sobi, Thermo Fisher Scientific) and four educational grant providers (Bristol Myers Squibb, Incyte, Lilly, Pfizer) supporting operations without direct influence over content. The platform is free to verified healthcare professionals, generating revenue through tiered sponsorship (Bronze Founder, Silver, Bronze, Contributor), independent educational grants, and a recently introduced user-contribution donation model via Stripe. Geographic reach is stated as global, with content restricted to HCPs and patients directed to the Lymphoma Coalition.

The go-to-motion is community-led: top-of-funnel acquisition comes through organic website content, congress coverage, and social media (X/Twitter); mid-funnel engagement is driven by newsletters, the personalization layer, steering committee meetings, and expert opinion interviews; and mid-funnel conversion to deeper engagement is reinforced through sponsored symposiums at major congresses. Strategic alliances with European LeukemiaNet (ELN) and the European Institute of Learning and Innovation (ELI) extend institutional reach into the European hematology research and learning ecosystem.

Name

Lymphoma Hub

Legal name

Lymphoma Hub

Website

https://lymphomahub.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Lymphoma Hub is an independent, UK-based medical education platform that delivers curated web content on lymphoma and CLL to hemato-oncology physicians globally, funded by pharmaceutical sponsorships and educational grants.

Ownership category

akta.pro rank

Product category

Medical Education

NAICS

Software Publishers (5132)

SIC

Services-Health Services (8000), Services-Prepackaged Software (7372)

akta.pro primary industry

Learning Experience Platforms (LXP) & Learning Portals (EDAFAAAB)

akta.pro secondary industries

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ), Core LMS Platforms (Academic & Corporate) (EDAFAAAA)

Keywords

• Medical education platform
• Lymphoma resources
• Hematology content
• Clinical trial information
• Continuing medical education

Headquarters

HQ city

Thames Ditton

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Technology or R&D, Operations, Others

Revenue model

1. Pharmaceutical Sponsorship: The Lymphoma Hub is sponsored by multiple pharmaceutical companies including AbbVie, BeOne Medicines, Caribou Biosciences, Miltenyi Biomedicine, Nurix Therapeutics, Roche, Sobi, and Thermo Fisher Scientific at various sponsorship levels (Bronze Founder, Silver, Bronze, Contributor).
2. Educational Grants: Supported through independent educational grants from Bristol Myers Squibb, Incyte, Lilly, and Pfizer. These grants fund content development while maintaining editorial independence.
3. Donations: The platform accepts one-off and repeat contributions from users, allowing healthcare professionals to support the platform's mission.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

The Lymphoma Hub is an independent medical education platform that aggregates and curates clinical and research content on lymphoma and chronic lymphocytic leukemia (CLL) for healthcare professionals worldwide. Its core product consists of curated content streams covering disease subtypes, treatment modalities, clinical trial data, drug approvals, expert opinion interviews, and live congress coverage, delivered through the lymphomahub.com website with personalization features for registered users.

Product overview

The Lymphoma Hub is an independent medical education platform focused on lymphoma and chronic lymphocytic leukemia (CLL), sponsored by pharmaceutical companies including AbbVie, BeOne Medicines, Caribou Biosciences, Miltenyi Biomedicine, Nurix Therapeutics, Roche, Sobi, and Thermo Fisher Scientific, with support from Bristol Myers Squibb, Incyte, Lilly, and Pfizer. The platform's core offering is My Lymphoma Hub, which provides personalized content and alerts for healthcare professionals. The platform aggregates educational content across multiple modules including Subtypes (covering all major lymphoma classifications), Therapeutics (covering all treatment modalities from antibody therapy to CAR-T), Congress Coverage (EHA, ICML, ASH), Clinical Trials Database, Expert Opinions, Drug Updates, and Educational Resources including Steering Committee Meetings and Symposiums. The content is developed independently by Scientific Education Support in collaboration with expert steering committees.

Differentiator

Problem solved

Functional benefit

Products and services

• The Lymphoma Hub Medical Education Platform An independent online medical education platform that provides hemato-oncology healthcare professionals with curated content on lymphoma and CLL, including disease subtypes, therapeutics, clinical trials, congress coverage, expert opinions, drug updates, and educational resources. Content is developed by Scientific Education Support in collaboration with an expert steering committee of key opinion leaders, with sponsors having no direct influence on content.
• My Lymphoma Hub A personalized account offering for healthcare professionals that enables bookmarking of site content, alerts for new content in the user's specified areas of interest, and recommendations of lymphoma and CLL content tailored to user preferences.

Quantifiable outcome

• The platform has been operational for over 10 years, indicating sustained relevance and trust within the medical community.

Segments1 record

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature3 records

Partnerships

Three partnerships are on record, tiered core and moderate.

• Scientific Education Support (SES)coreStrategic or Co-development PartnerSES is the parent organization that develops and manages the Lymphoma Hub. SES delivers streamlined independent medical education in partnership with expert steering committees. SES develops all content independently while the platform is funded by pharmaceutical sponsors.
• European LeukemiaNet (ELN)moderateStrategic or Co-development PartnerPartnership with European LeukemiaNet provides additional credibility and alignment with European hematology research community.
• European Institute of Learning and Innovation (ELI)moderateStrategic or Co-development PartnerPartnership with European Institute of Learning and Innovation for educational collaboration.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Market position

Weaknesses5 records

Competitive moat5 records

Key highlights7 records

Customer concentration

• Xx.com/lymphomahub
• Facebookfacebook.com/lymphomahub
• LinkedInlinkedin.com/company/lymphoma-hub

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lymphoma Hub